Yeah I'll hold onto it. It's gonna be a long play stock though.We still holding on to CRMD brehs? I saw a lot of talk about it today and it was on the rise.
Yeah I'll hold onto it. It's gonna be a long play stock though.We still holding on to CRMD brehs? I saw a lot of talk about it today and it was on the rise.
We still holding on to CRMD brehs? I saw a lot of talk about it today and it was on the rise.
Im not selling cormedix for anything less than $20 a share. Maybe a good day trade option but I dont day trade. With CRMD I want to make thousands not hundreds.
Yep...long term play here.Yeah I'll hold onto it. It's gonna be a long play stock though.
I'm looking at buying more today to average my cost down. I'm at 1.92 cost basis right now. The stock is in the 1.70s.Yep...long term play here.
That stock would have been useful a little over a month ago. Not now.Small biotech company BPTH got good phase II results and the stock went from $10.20 to a high of $74 and now settled at $38, it was $2 a month ago. I think they got good results on a cancer drug they have. I can't wait for the day one of my stocks go parabolic
Yahoo is now part of Oath
That was actually just a follow up to my more recent post about biotech stocks and why it might not be good to sell if it only jumps a couple of dollars because it has a lot more room to run. Not only that but when BPTH settles back down its a decent opportunity to buy because with it only being phase II results its gonna get higher with each catalyst ultimately being FDA approval and a buyout. Even though I didn't catch it at $2, this is still a approval/buyout play even novice investors can see that all you have to do is due diligenceThat stock would have been useful a little over a month ago. Not now.
I'm listing all of mine in real time. That's what this thread is for.
I'm still mad I never bought GSUM but live and learn.
OK. I would also check their cash/future funding. Each trial costs millions of dollars which is why biotechs sink so much on bad news/test resultsThat was actually just a follow up to my more recent post about biotech stocks and why it might not be good to sell if it only jumps a couple of dollars because it has a lot more room to run. Not only that but when BPTH settles back down its a decent opportunity to buy because with it only being phase II results its gonna get higher with each catalyst ultimately being FDA approval and a buyout. Even though I didn't catch it at $2, this is still a approval/buyout play even novice investors can see that all you have to do is due diligence
They report next Thursday after the bell.CRMD... I'm still holding...
They report next Thursday after the bell.
Definitely gonna load up some more before then... what's the outlook looking like???
Seeking FDA approval on a drug that prevents catheter infections. Not very close to getting that approval at the moment.anyone can give me a lil info on CRMD.
I have a little on $1700 of stock I can buy Monday and looking for something a cheap that I can flip.
Thanks.